Westlake Chemical Partners (NYSE:WLKP - Get Free Report) is expected to be releasing its Q2 2025 earnings data before the market opens on Tuesday, August 5th. Analysts expect Westlake Chemical Partners to post earnings of $0.44 per share for the quarter.
Westlake Chemical Partners (NYSE:WLKP - Get Free Report) last posted its earnings results on Friday, May 2nd. The basic materials company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.38 by ($0.24). The company had revenue of $237.63 million for the quarter, compared to the consensus estimate of $296.00 million. Westlake Chemical Partners had a return on equity of 6.35% and a net margin of 4.82%. On average, analysts expect Westlake Chemical Partners to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Westlake Chemical Partners Price Performance
Shares of NYSE WLKP traded down $0.23 during midday trading on Friday, reaching $21.80. 49,595 shares of the company were exchanged, compared to its average volume of 29,631. The stock has a market cap of $768.09 million, a P/E ratio of 14.63 and a beta of 0.78. Westlake Chemical Partners has a one year low of $21.19 and a one year high of $25.04. The stock's 50-day moving average price is $22.16 and its 200-day moving average price is $23.02. The company has a quick ratio of 1.35, a current ratio of 1.37 and a debt-to-equity ratio of 0.50.
Westlake Chemical Partners Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Shareholders of record on Tuesday, August 12th will be given a dividend of $0.4714 per share. The ex-dividend date of this dividend is Tuesday, August 12th. This represents a $1.89 dividend on an annualized basis and a yield of 8.7%. Westlake Chemical Partners's dividend payout ratio is 126.85%.
Insider Activity
In other news, Chairman James Chao sold 5,608 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $22.17, for a total transaction of $124,329.36. Following the transaction, the chairman owned 8,300 shares of the company's stock, valued at $184,011. This represents a 40.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders have sold 13,908 shares of company stock worth $307,759. 1.10% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Westlake Chemical Partners
A hedge fund recently raised its stake in Westlake Chemical Partners stock. Goldman Sachs Group Inc. raised its position in Westlake Chemical Partners LP (NYSE:WLKP - Free Report) by 3.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 228,885 shares of the basic materials company's stock after buying an additional 8,424 shares during the period. Goldman Sachs Group Inc. owned 0.65% of Westlake Chemical Partners worth $5,285,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 78.28% of the company's stock.
Wall Street Analyst Weigh In
Separately, Wall Street Zen downgraded Westlake Chemical Partners from a "strong-buy" rating to a "buy" rating in a report on Monday, May 5th.
Check Out Our Latest Report on WLKP
About Westlake Chemical Partners
(
Get Free Report)
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
Featured Articles

Before you consider Westlake Chemical Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Westlake Chemical Partners wasn't on the list.
While Westlake Chemical Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.